Tucatinib 50 mg, 150 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg, 150 mg
Reference Brands: Tukysa (USA, EU/UK), Tukavo (India)
Category: Oncology Cancer Care
Tucatinib is a Oncology Cancer Care product available as Tablets in strengths 50 mg, 150 mg. It corresponds to the reference brands Tukysa (USA, EU/UK), Tukavo (India). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Tucatinib is an oral anticancer medication used in the treatment of HER2-positive cancers, particularly advanced or metastatic breast cancer. It is a small-molecule inhibitor that selectively targets the human epidermal growth factor receptor 2 (HER2), a protein that promotes the growth of certain cancer cells. By blocking HER2 signaling pathways, tucatinib helps slow down tumor growth and reduce the spread of cancer. This targeted mechanism allows it to work effectively while minimizing effects on other receptors compared to some older therapies.
Tucatinib is commonly used in combination with other anticancer medicines such as trastuzumab and capecitabine to improve treatment outcomes in patients who have previously received other HER2-directed therapies. One of the important advantages of tucatinib is its ability to provide benefits for patients whose cancer has spread to the brain, a condition that can be difficult to treat with many standard therapies. The medicine is administered orally in tablet form, making it convenient for ongoing treatment.
Overall, tucatinib represents an important advancement in targeted oncology therapy, offering an additional option for managing HER2-positive cancers and improving disease control in patients with advanced stages of the disease.
Tucatinib — third party manufacturing & bulk supply
Tucatinib 50 mg, 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tucatinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tucatinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tucatinib is used, in combination with trastuzumab and capecitabine, to treat adults with HER2-positive locally advanced or metastatic breast cancer, including patients with brain metastases, who have received prior anti-HER2 therapies. It is also approved in combination with trastuzumab for RAS wild-type, HER2-positive metastatic colorectal cancer after certain chemotherapy regimens.
Tucatinib is a small-molecule tyrosine kinase inhibitor that selectively targets the HER2 receptor inside cancer cells, blocking signaling pathways that promote tumor growth and survival.
The main trade name of Tucatinib is Tukysa, while generic brands include Tukavo in certain markets.
Tucatinib (Tukysa) is manufactured and marketed by Seagen Inc. in collaboration with partners; generic versions like Tukavo are manufactured by companies such as Zydus Lifesciences in select regions.
The generic name is Tucatinib.
The brand names are Tukysa (USA, EU/UK) and Tukavo (India/emerging markets).
Tucatinib is manufactured in facilities in the USA and other approved global sites; generic versions are produced in India and other emerging markets for regional distribution.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
